Cipher Pharmaceuticals Inc. (CPH) Analysts See $0.10 EPS; Shorts at Abbott Laboratories (ABT) Raised By 0.19% - Lives Advice

Cipher Pharmaceuticals Inc. (CPH) Analysts See $0.10 EPS; Shorts at Abbott Laboratories (ABT) Raised By 0.19%  Lives Advice

Analysts expect Cipher Pharmaceuticals Inc. (TSE:CPH) to report $0.10 EPS on February, 27.They anticipate $0.09 EPS change or 47.37% from last quarter's ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more